ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis
Europe - BIT:1ANTM - US0367521038 - Common Stock
302.3 EUR
+40.8 (+15.6%)
Overall 1ANTM gets a fundamental rating of 4 out of 10. We evaluated 1ANTM against 32 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of 1ANTM while its profitability can be described as average. 1ANTM is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
1ANTM had positive earnings in the past year.
1ANTM had a positive operating cash flow in the past year.
In the past 5 years 1ANTM has always been profitable.
In the past 5 years 1ANTM always reported a positive cash flow from operatings.
1.2 Ratios
1ANTM's Return On Assets of 4.40% is fine compared to the rest of the industry. 1ANTM outperforms 78.13% of its industry peers.
Looking at the Return On Equity, with a value of 12.26%, 1ANTM is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
The Return On Invested Capital of 1ANTM (5.90%) is comparable to the rest of the industry.
1ANTM had an Average Return On Invested Capital over the past 3 years of 6.90%. This is in line with the industry average of 6.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROIC | 5.9% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
With a Profit Margin value of 2.83%, 1ANTM perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
In the last couple of years the Profit Margin of 1ANTM has declined.
With a Operating Margin value of 4.60%, 1ANTM perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
1ANTM's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
1ANTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
1ANTM has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1ANTM has less shares outstanding
1ANTM has a worse debt/assets ratio than last year.
2.2 Solvency
1ANTM has a debt to FCF ratio of 5.70. This is a neutral value as 1ANTM would need 5.70 years to pay back of all of its debts.
1ANTM has a better Debt to FCF ratio (5.70) than 68.75% of its industry peers.
1ANTM has a Debt/Equity ratio of 0.65. This is a neutral value indicating 1ANTM is somewhat dependend on debt financing.
1ANTM's Debt to Equity ratio of 0.65 is fine compared to the rest of the industry. 1ANTM outperforms 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Altman-Z | N/A |
ROIC/WACC0.69
WACC8.49%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
The earnings per share for 1ANTM have decreased by -6.64% in the last year.
Measured over the past years, 1ANTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
Looking at the last year, 1ANTM shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
The Revenue has been growing by 11.14% on average over the past years. This is quite good.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
3.2 Future
1ANTM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
Based on estimates for the next years, 1ANTM will show a quite strong growth in Revenue. The Revenue will grow by 8.96% on average per year.
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y8.79%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.74 indicates a reasonable valuation of 1ANTM.
90.63% of the companies in the same industry are more expensive than 1ANTM, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.86, 1ANTM is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.25, the valuation of 1ANTM can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ANTM indicates a somewhat cheap valuation: 1ANTM is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.32. 1ANTM is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.74 | ||
| Fwd PE | 11.25 |
4.2 Price Multiples
1ANTM's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1ANTM.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.09 | ||
| EV/EBITDA | 9.94 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y-2.2%
EPS Next 3Y3%
5. Dividend
5.1 Amount
1ANTM has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.38, 1ANTM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, 1ANTM has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
5.2 History
The dividend of 1ANTM is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
28.40% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y-2.2%
EPS Next 3Y3%
BIT:1ANTM (10/3/2025, 7:00:00 PM)
302.3
+40.8 (+15.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap68.07B
Analysts76.43
Price Target317.93 (5.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
Yearly Dividend5.61
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-24.28%
PT rev (3m)-34.2%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)-42.6%
EPS NY rev (1m)-13.11%
EPS NY rev (3m)-12.64%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.74 | ||
| Fwd PE | 11.25 | ||
| P/S | 0.42 | ||
| P/FCF | 15.09 | ||
| P/OCF | 12.46 | ||
| P/B | 1.83 | ||
| P/tB | 20.67 | ||
| EV/EBITDA | 9.94 |
EPS(TTM)28.14
EY9.31%
EPS(NY)26.87
Fwd EY8.89%
FCF(TTM)20.03
FCFY6.63%
OCF(TTM)24.26
OCFY8.02%
SpS716.26
BVpS165.47
TBVpS14.62
PEG (NY)N/A
PEG (5Y)0.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROCE | 7.72% | ||
| ROIC | 5.9% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 11.77% | ||
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A | ||
| FCFM | 2.8% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 75.47% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.96% | ||
| Profit Quality | 98.73% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC8.49%
ROIC/WACC0.69
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y8.79%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%